- Release Date: 13/03/23 09:10
- Summary: FDA approves Daybue - the first treatment for Rett syndrome
- Price Sensitive: Yes
- Download Document 258.83KB
Ann: FDA approves Daybue - the first treatment for Rett syndrome
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.59 |
Change
-0.270(1.29%) |
Mkt cap ! $2.602B | |||
| Open | High | Low | Value | Volume |
| $20.45 | $20.61 | $20.26 | $1.402M | 68.57K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $20.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.60 | 74 | 2 |
View Market Depth
| Last trade - 11.34am 27/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |